Product Pipeline
C-1205 (CAUTI)
C-1205 is used to prevent catheter-associated urinary tract infections (CAUTIs). The active ingredient of C-1205 is a naturally-occurring E. coli strain that is able to out-compete and prevent pathogenic bacteria from causing CAUTIs.
B-4474 (Wound Infections)
B-4474 is used to treat wound infections. The initial indication will be to treat resistant infections of large wounds caused by Gram negative bacteria. The donor bacterium in this product can effectively kill every Gram negative target strain that we have tested against, including strains of Pseudomonas aeruginosa and Acinetobacter baumannii that are pan-resistant.
Latest News
05 Dec 2007
ConjuGon to Receive $1.2 Million from Department of Defense
02 May 2007
ConjuGon to Present at BIO 2007
13 Dec 2006
ConjuGon Raises $3.3 Million